Serotonin transporter genotype and acute subjective response to amphetamine - PubMed (original) (raw)
Randomized Controlled Trial
. 2006 Sep-Oct;15(5):327-35.
doi: 10.1080/10550490600859868.
Affiliations
- PMID: 16966188
- DOI: 10.1080/10550490600859868
Randomized Controlled Trial
Serotonin transporter genotype and acute subjective response to amphetamine
David C Lott et al. Am J Addict. 2006 Sep-Oct.
Abstract
The authors have previously shown an effect of dopamine transporter genotype on acute subjective responses to d-amphetamine, which may affect risk of addiction. They now report the results of an evaluation of the role of the serotonin transporter gene (HTT) using a double-blind, placebo-controlled, crossover design in which subjects (N = 101) completed self-report measures of subjective effect. The separate and combined analyses of the gene-linked polymorphic region (5-HTTLPR) and the Intron 2 VNTR suggest that these two HTT polymorphisms may contribute to acute subjective responses to d-amphetamine with a small effect.
Similar articles
- Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder.
Tharoor H, Kotambail A, Jain S, Sharma PS, Satyamoorthy K. Tharoor H, et al. Psychiatr Genet. 2013 Apr;23(2):77-81. doi: 10.1097/YPG.0b013e32835d6fad. Psychiatr Genet. 2013. PMID: 23277128 - Association of the DRD4 exon III and 5-HTTLPR VNTR polymorphisms with substance abuse in Jordanian Arab population.
Al-Eitan LN, Alshudaifat KM, Anani JY. Al-Eitan LN, et al. Gene. 2020 Apr 5;733:144267. doi: 10.1016/j.gene.2019.144267. Epub 2019 Dec 3. Gene. 2020. PMID: 31809838 - Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters.
Bah J, Lindström M, Westberg L, Mannerås L, Ryding E, Henningsson S, Melke J, Rosén I, Träskman-Bendz L, Eriksson E. Bah J, et al. Psychiatry Res. 2008 Apr 15;162(3):221-9. doi: 10.1016/j.pscychresns.2007.07.004. Psychiatry Res. 2008. PMID: 18314311 - Association of 5-HTT gene polymorphisms with migraine: a systematic review and meta-analysis.
Liu H, Liu M, Wang Y, Wang XM, Qiu Y, Long JF, Zhang SP. Liu H, et al. J Neurol Sci. 2011 Jun 15;305(1-2):57-66. doi: 10.1016/j.jns.2011.03.016. Epub 2011 Mar 30. J Neurol Sci. 2011. PMID: 21450309 Review. - Behavioural genetics of the serotonin transporter.
Haddley K, Bubb VJ, Breen G, Parades-Esquivel UM, Quinn JP. Haddley K, et al. Curr Top Behav Neurosci. 2012;12:503-35. doi: 10.1007/7854_2011_186. Curr Top Behav Neurosci. 2012. PMID: 22261701 Review.
Cited by
- Affective response to physical activity as a deep phenotype in a non-randomized pilot study.
Lee HH, McGeary JE, Dunsiger S, Emerson JA, Bock B, McCaffery J, Dwyer K, Bryan AD, Williams DM. Lee HH, et al. Sci Rep. 2022 Apr 7;12(1):5893. doi: 10.1038/s41598-022-09662-3. Sci Rep. 2022. PMID: 35393456 Free PMC article. - Subjective effects to marijuana associated with marijuana use in community and clinical subjects.
Zeiger JS, Haberstick BC, Corley RP, Ehringer MA, Crowley TJ, Hewitt JK, Hopfer CJ, Stallings MC, Young SE, Rhee SH. Zeiger JS, et al. Drug Alcohol Depend. 2010 Jun 1;109(1-3):161-6. doi: 10.1016/j.drugalcdep.2009.12.026. Epub 2010 Feb 9. Drug Alcohol Depend. 2010. PMID: 20149559 Free PMC article. - Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.
Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA. Bryant CD, et al. Neuropsychopharmacology. 2012 Mar;37(4):1026-35. doi: 10.1038/npp.2011.287. Epub 2011 Nov 16. Neuropsychopharmacology. 2012. PMID: 22089318 Free PMC article. - Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
Hart AB, Engelhardt BE, Wardle MC, Sokoloff G, Stephens M, de Wit H, Palmer AA. Hart AB, et al. PLoS One. 2012;7(8):e42646. doi: 10.1371/journal.pone.0042646. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952603 Free PMC article. - Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults.
Leventhal AM, Kirkpatrick MG, Pester MS, McGeary JE, Swift RM, Sussman S, Kahler CW. Leventhal AM, et al. Psychopharmacology (Berl). 2017 Jan;234(2):307-315. doi: 10.1007/s00213-016-4462-z. Epub 2016 Oct 22. Psychopharmacology (Berl). 2017. PMID: 27771748 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources